Literature DB >> 2213745

Computed tomographic and ultrasonographic findings in women with acute fatty liver of pregnancy.

L Van Le1, A Podrasky.   

Abstract

Acute fatty liver of pregnancy is associated with complications that can influence antepartum management and necessitate delivery. To date, liver biopsy has been regarded as the "gold standard" for diagnosis. Radiologic evaluation of the liver has been suggested as a less invasive means of diagnosing this entity. Five patients with acute fatty liver of pregnancy underwent ultrasonography; three underwent concomitant computed tomography (CT) of the liver. The liver appeared to be normal in all the patients undergoing CT evaluation and all undergoing ultrasonography except one. Normal liver examinations are not unusual findings in patients with acute fatty liver of pregnancy.

Entities:  

Mesh:

Year:  1990        PMID: 2213745

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Acute abdominal and pelvic pain in pregnancy: ESUR recommendations.

Authors:  Gabriele Masselli; Lorenzo Derchi; Josephine McHugo; Andrea Rockall; Peter Vock; Michael Weston; John Spencer
Journal:  Eur Radiol       Date:  2013-08-30       Impact factor: 5.315

2.  Multimodality imaging of hepato-biliary disorders in pregnancy: a pictorial essay.

Authors:  Eugene M W Ong; Jennifer S Drukteinis; Hope E Peters; Koenraad J Mortelé
Journal:  Emerg Radiol       Date:  2009-02-19

3.  Measurement of left portal vein blood-flow velocity by Doppler sonography in a patient with acute fatty liver of pregnancy.

Authors:  Seishiro Watanabe; Naohito Uchida; Tsutomu Masaki; Kazutaka Kurokohchi; Tetsuo Toge; Shigeki Kuriyama; Yooichi Ohnishi; Hirokazu Tanaka; Takaaki Kurose; Toshiyuki Hata
Journal:  J Med Ultrason (2001)       Date:  2003-03       Impact factor: 1.314

Review 4.  Pregnancy-associated liver disorders.

Authors:  Iryna S Hepburn; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-02-07       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.